General Information of the Molecule (ID: Mol01133)
Name
Undecaprenyl-diphosphatase BcrC (BCRC) ,Bacillus subtilis
Synonyms
Undecaprenyl pyrophosphate phosphatase; ywoA; BSU36530
    Click to Show/Hide
Molecule Type
Protein
Gene Name
bcrC
Gene ID
936946
Sequence
MNYEIFKAIHGLSHHNSVLDSIMVFITEYAIVAYALILLAIWLFGNTQSRKHVLYAGITG
IAGLVINYLITLVYFEPRPFVAHTVHTLIPHAADASFPSDHTTGALAISIAMLFRNRKIG
WPLVIFGLLTGFSRIWVGHHYPVDVLGSLVVAIIIGFLFFRFSDLLRPFVDLVVRIYEAI
INKLTKKPTDQNF
    Click to Show/Hide
Function
Catalyzes the dephosphorylation of undecaprenyl diphosphate (UPP). Confers resistance to bacitracin.
    Click to Show/Hide
Uniprot ID
BCRC_BACSU
        Click to Show/Hide the Complete Species Lineage
Kingdom: N.A.
Phylum: Firmicutes
Class: Bacilli
Order: Bacillales
Family: Bacillaceae
Genus: Bacillus
Species: Bacillus subtilis
Type(s) of Resistant Mechanism of This Molecule
  ADTT: Aberration of the Drug's Therapeutic Target
Drug Resistance Data Categorized by Drug
Approved Drug(s)
3 drug(s) in total
Click to Show/Hide the Full List of Drugs
Bacitracin A
Click to Show/Hide
Drug Resistance Data Categorized by Their Corresponding Mechanisms
       Aberration of the Drug's Therapeutic Target (ADTT) Click to Show/Hide
Disease Class: Bacillus subtilis infection [1]
Resistant Disease Bacillus subtilis infection [ICD-11: 1G40.1]
Resistant Drug Bacitracin A
Molecule Alteration Expression
Inherence
Experimental Note Discovered Using In-vivo Testing Model
In Vitro Model Escherichia coli C41(DE3) 469008
Escherichia coli DH5alpha 668369
Bacillus subtilis 168 224308
Bacillus subtilis BFS82 1423
Bacillus subtilis BSmrs168 1423
Bacillus subtilis BSmrs173 1423
Bacillus subtilis BSmrs175 1423
Bacillus subtilis BSmrs194 1423
Bacillus subtilis BSmrs201 1423
Escherichia coli Ecmrs144 562
Escherichia coli Ecmrs150 562
Escherichia coli Ecmrs151 562
Experiment for
Molecule Alteration
PCR amplification and DNA sequence assay
Experiment for
Drug Resistance
Microtiter tray assay
Mechanism Description Overexpression of the BcrCBs protein, formerly called YwoA, in Escherichia coli or in Bacillus subtilis allows these bacteria to stand higher concentrations of bacitracin.
Bacitracin F
Click to Show/Hide
Drug Resistance Data Categorized by Their Corresponding Mechanisms
       Aberration of the Drug's Therapeutic Target (ADTT) Click to Show/Hide
Disease Class: Bacillus subtilis infection [1]
Resistant Disease Bacillus subtilis infection [ICD-11: 1G40.1]
Resistant Drug Bacitracin F
Molecule Alteration Expression
Inherence
Experimental Note Discovered Using In-vivo Testing Model
In Vitro Model Escherichia coli C41(DE3) 469008
Escherichia coli DH5alpha 668369
Bacillus subtilis 168 224308
Bacillus subtilis BFS82 1423
Bacillus subtilis BSmrs168 1423
Bacillus subtilis BSmrs173 1423
Bacillus subtilis BSmrs175 1423
Bacillus subtilis BSmrs194 1423
Bacillus subtilis BSmrs201 1423
Escherichia coli Ecmrs144 562
Escherichia coli Ecmrs150 562
Escherichia coli Ecmrs151 562
Experiment for
Molecule Alteration
PCR amplification and DNA sequence assay
Experiment for
Drug Resistance
Microtiter tray assay
Mechanism Description Overexpression of the BcrCBs protein, formerly called YwoA, in Escherichia coli or in Bacillus subtilis allows these bacteria to stand higher concentrations of bacitracin.
Bacitracin methylene disalicylate
Click to Show/Hide
Drug Resistance Data Categorized by Their Corresponding Mechanisms
       Aberration of the Drug's Therapeutic Target (ADTT) Click to Show/Hide
Disease Class: Bacillus subtilis infection [1]
Resistant Disease Bacillus subtilis infection [ICD-11: 1G40.1]
Resistant Drug Bacitracin methylene disalicylate
Molecule Alteration Expression
Inherence
Experimental Note Discovered Using In-vivo Testing Model
In Vitro Model Escherichia coli C41(DE3) 469008
Escherichia coli DH5alpha 668369
Bacillus subtilis 168 224308
Bacillus subtilis BFS82 1423
Bacillus subtilis BSmrs168 1423
Bacillus subtilis BSmrs173 1423
Bacillus subtilis BSmrs175 1423
Bacillus subtilis BSmrs194 1423
Bacillus subtilis BSmrs201 1423
Escherichia coli Ecmrs144 562
Escherichia coli Ecmrs150 562
Escherichia coli Ecmrs151 562
Experiment for
Molecule Alteration
PCR amplification and DNA sequence assay
Experiment for
Drug Resistance
Microtiter tray assay
Mechanism Description Overexpression of the BcrCBs protein, formerly called YwoA, in Escherichia coli or in Bacillus subtilis allows these bacteria to stand higher concentrations of bacitracin.
References
Ref 1 BcrC from Bacillus subtilis acts as an undecaprenyl pyrophosphate phosphatase in bacitracin resistance. J Biol Chem. 2005 Aug 12;280(32):28852-7. doi: 10.1074/jbc.M413750200. Epub 2005 Jun 9.

If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.